J Korean Gastric Cancer Assoc.  2001 Dec;1(4):221-227.

Prospective Randomized Trial for Postoperative Adjuvant Chemotherapy in Gastric Cancer Patients without Serosal Invasion: Preliminary Report

Affiliations
  • 1Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. bskim@www.amc.seoul.kr

Abstract

PURPOSE: We have carried out prospective randomized clinical trial to compare survival benefit and side effect among three postoperative adjuvant chemotherapeutic regimens in serosa-negative gastric cancer patients. MATENRIALS AND METHODS: Total 317 cases were recognized as serosa negative and randomized into three groups at operating room. Out of them, 172 cases were excluded because of various reasons and 135 cases were analyzed finally; Group A 36 cases, Group B 49 cases, Group C 50 cases. Group A were treated with intravenous FP combination therapy, group B with MF combination therapy and group C with oral UFT(R) (mixture of Tegafur and Uracil) for one year. The median follow-up period was 30 months.
RESULTS
88.9% of Group A, 83.7% of Group B and 90.4% of Group C received adequate chemotherapy. The complication rates of Group A (44.4%) was significantly higher than group B (20.4%) and group C (24.0%)(P<0.05). Most frequent complications were nausea and vomiting. The 3-year survival rates and disease-free survival rates were 92.2% and 89.9% respectively (Group A: 96.6%, 87.8%, B: 90.3%, 87.7%, C: 95.7%, 93.8%). There were no significant differences in survival rate and disease-free survival rate among the three groups (P>0.05).
CONCLUSION
This study might suggest that the survival benefit of postoperative adjuvant chemotherapy for gastric Pseudomonas aeruginosa, and therefore it may be a useful adjunct tool for detection of Pseudomonas aeruginosa infection in combination with other conventional techniques.

Keyword

Gastric cancer; Adjuvant chemotherapy; Toxicity; Survival rate

MeSH Terms

Chemotherapy, Adjuvant*
Disease-Free Survival
Drug Therapy
Follow-Up Studies
Humans
Nausea
Operating Rooms
Prospective Studies*
Pseudomonas aeruginosa
Psychotherapy, Group
Serous Membrane
Stomach Neoplasms*
Survival Rate
Tegafur
Vomiting
Tegafur
Full Text Links
  • JKGCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr